Citi upgrades Astellas Pharma Inc. to Buy

  • Investing.com
Citi upgrades Astellas Pharma Inc. to Buy

A Citi analyst upgraded Astellas Pharma Inc. (TYO: 4503) from Neutral to Buy with a price target of $2600.00 from a prior price target of JPY2100.00.

Prior to this rating, Astellas Pharma Inc. had 11 buy ratings, 1 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Astellas Pharma Inc., click here. For more news on Astellas Pharma Inc., click here.

Astellas Pharma Inc.'s stock price closed at $1.0. They are up 0% in the last month and down -1.8% in the last 12 months.

According to Investing Pro, Astellas Pharma Inc.'s fair value is $2.4K, an upside of 20.5%. Astellas Pharma Inc.'s fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Astellas Pharma Inc.'s recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100